Estimation of the Seroprevalence and Infection Fatality Rate of the SARS-CoV-2 Omicron Variant Using Antibody Screening of Danish Blood Donors
Christian Erikstrup(Aarhus University Hospital), Ole Birger Pedersen(University of Copenhagen), Thorsten Brodersen(Zealand University Hospital Køge), Steen Ethelberg(Statens Serum Institut), Christina Mikkelsen(University of Exeter), Susan Mikkelsen(Aarhus University Hospital), Henrik Ullum(Statens Serum Institut), Erik Sørensen(Copenhagen University Hospital), Laura Espenhain(Statens Serum Institut), Josephine Gladov(Aarhus University Hospital), Jens Kjærgaard Boldsen(Aarhus University Hospital), Signe Winther Jørgensen(Aarhus University Hospital), Michael Schwinn(University of Exeter), Dorte Kinggaard Holm(Odense University Hospital), Mie Topholm(Odense University Hospital), Sisse Rye Ostrowski(University of Copenhagen), Kathrine Agergård Kaspersen(Aarhus University Hospital), Michael P. Busch(Vitalant), Tyra Grove Krause(Statens Serum Institut), Bitten Aagaard(Rigshospitalet), Janna Nissen(Copenhagen University Hospital), Khoa Manh Dinh(Aarhus University Hospital), Charlotte Sværke Jørgensen(Statens Serum Institut), Lene Holm Harritshøj(University of Copenhagen), Susanne Gjørup Sækmose(Zealand University Hospital), Anna Laksafoss(Statens Serum Institut), Lotte Hindhede(Aarhus University Hospital)
Cited by 0
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718